Symbio Pharmaceuticals (4582 JP): Q3 FY12/25 flash update
Sales dropped 48.9% YoY to JPY971mn, with a gross profit margin of 71.6%, down 4.5pp YoY. Operating loss was JPY3.3bn, compared to a loss of...
401 Views
Symbio Pharmaceuticals (4582 JP): 1H FY12/25 flash update
Sales dropped 49.7% YoY to JPY647mn, with a gross profit margin of 76.3%, down 1.3pp YoY. Operating loss reached JPY2.2bn, recurring loss...
134 Views
Symbio Pharmaceuticals (4582 JP): Q1 FY12/25 flash update
Sales dropped 55.8% YoY to JPY264mn due to generic competition and inventory adjustments ahead of drug price revision. SG&A expenses rose 7.3%...
198 Views
Symbio Pharmaceuticals (4582 JP): Full-year FY12/24 flash update
Sales decreased by 56.1% YoY to JPY2.5bn, with a gross profit of JPY1.9bn and a gross margin of 76.4%. Operating loss increased to JPY3.9bn in...
165 Views
Symbio Pharmaceuticals (4582 JP): Q3 FY12/24 flash update
Sales decreased by 57.1% YoY to JPY1.9bn, with operating, recurring, and net losses each at JPY2.8bn. SG&A expenses increased by 12.7% YoY to...
198 Views